Advertisement

Die Vaginalsonographie in der Postmenopause zur Endometriumdiagnostik

  • R. G. W. Osmers
Conference paper

Zusammenfassung

Im Gegensatz zum Kollumkarzinom verzeichnen die meisten Industrienationen ein stetiges Ansteigen der Inzidenz des Endometriumkarzinoms. Wenn auch dieses Malignom des weiblichen Genitales sich überwiegend zum Zeitpunkt der klinischen Erstmanifestation zu annähernd 90% in den vermeintlich günstigen Stadien FIGO I und II befinden, wobei die 5-Jahres-Überlebensquote im Stadium FIGO I 75–90% beträgt. Analysiert man dieses scheinbar prognostisch günstige Stadium, so zeigt sich, daß bei Infiltration des Tumors in das äußere Drittel des Myometriums die 5-Jahres-Überlebensquote auf 33% von 90% bei Infiltration des inneren Drittels sinkt [1]. Es muß daher konstatiert werden, daß die myometrane Infiltration zu den bedeutenden Risikofaktoren des Endometriumkarzinoms gezählt werden muß [2].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Baltzer J, Lohe K (1986) Präneoplasien und Karzinome des Endometriums. In: Schmidt-Matthiesen H (Hrsg) Spezielle gynäkologische Onkologie I, 2. Aufl, S 231–263Google Scholar
  2. 2.
    Creasman WT, Weed JC (1981) Carcinoma of endometrium (Figo stages I & II): clinical features and management. In: Copplesond M (ed) Gynecologic Oncology. Churchill Livingston, Edinburg, pp 562–577Google Scholar
  3. 3.
    Kurman RJ, Norris HJ (1987) Endometrial carcinoma. In: Kurman RG (ed) Blaustein’s pathology of the female genital tract, 3. ed. Springer, New YorkGoogle Scholar
  4. 4.
    Bachet W, Brunner P, Dodenhöfer JDJ, Strobel E (1983) Diagnostische Treffsicherheit der Endometriumzytologie mit Prevical. Geburtsh Frauenheilkd 43: 11–14CrossRefGoogle Scholar
  5. 5.
    Iversen 0E, Sagadal E (1985) The value of endometrial cytology. A comparative study of the Graulee Jet-Washer, Isaccs Cell Sampcher and Endoscan versus curettage in boo patients. Obstet Gynecol Sury 4o: 14–20Google Scholar
  6. 6.
    Mestwerdt W, Kranzfelder D (1983) Neue diagnostische Möglichkeiten beim Endometriumkarzinom und seinen Vorstufen. Gynäkologe 16: 87–92PubMedGoogle Scholar
  7. 7.
    Kurman RJ, Kaminski PF, Norris HJ (1985) The behaviour of endometrial hyperplasia, a longterm study of “untreated” hyperplasia in 170 patients. Cancer 56: 403–412PubMedCrossRefGoogle Scholar
  8. 8.
    King R, Townsend PT, Siddle N, Whitehead MI, Taylor RW (1982) Regulation of estrogen and progesterone receptor levels in epithelian and stroma from pre-and postmenopausal endometria. J Steroid Biochem 16: 21–29PubMedCrossRefGoogle Scholar
  9. 9.
    Tavassoli F, Kraus FT (1978) Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol 7o: 77o - 779Google Scholar
  10. 10.
    Gusberg SB (1962) Therapeutic implications of endometrial hyperplasia. Acad Med New Jersey Bull 8: 207–279PubMedGoogle Scholar
  11. 11.
    Osmers E, Voelksen M, Schauer A (199o) Vaginosonography for early detection of endometrial carcinoma? Lancet 335: 1569–1571Google Scholar
  12. 12.
    Abu Hmeidan F, Baier D, Bilck K (1991) Sonographic studies of patients with postmenopausal hemorrhage (endometrium/myometrium index). Zbl Gynäkol 113: 707–712Google Scholar
  13. 13.
    Granberg S, Norstrom A, Wikland M (199o) Tumor in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 37: 224–229Google Scholar
  14. 14.
    Karlsson B, Granberg S, Wikland M, Ryd W, Norstrom A (1993) Endovaginal scanning of the endometrium compared to cytology and histology in women with postmenopausal bleeding. Gynecol Oncol 50: 173–178PubMedCrossRefGoogle Scholar
  15. 15.
    Brandner P, Gnirs J, Neis KJ, Hettenbach A, Schmidt W (1991) Value of vaginal ultrasonography in noninvasive assessment of the endometrium of the postmenopausal uterus. Geburtsh Frauenheilkd 51: 734–740CrossRefGoogle Scholar
  16. 16.
    Seelbach-Göbel B, Rempen A, Kristen P (1991) Vaginal sonography of the endometrium in post-menopause. Initial results of a prospective study. Gynäkol Rdsch 31 (Suppl 2): 253–255CrossRefGoogle Scholar
  17. 17.
    Osmers R, Völksen M, Kuhn W (1992) Evaluation of the endometrium in postmenopausal women by means of vaginal ultrasound. Rev Fr Gynecol Obstet 87: 309–315PubMedGoogle Scholar
  18. 18.
    Granberg S, Wikland M, Karlsson B, Norstrom A, Friberg LG (1991) Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 164: 47–52PubMedGoogle Scholar
  19. 19.
    Dorum A, Kristensen GB, Langebrekke A, Sornes T, Skaar 0 (1993) Evaluation of endometrial thickness measured by endovaginal ultrasound in women with postmenopausal bleeding. Acta Ob-stet Gynecol Scand 72: 116–119Google Scholar
  20. 20.
    Ghirardini G, Montanans M, Gualerzi C (1990) Carcinoma and endometrial thickness (letter comment). Lancet 335: 1569–1571CrossRefGoogle Scholar
  21. 21.
    Varner RE, Sparks JM, Cameron CD, Roberts LL, Soong SI (1991) Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 199: 195–199Google Scholar
  22. 22.
    Weigel M, Schmitt W, Melchert W (1992) Die Eignung metrisch-struktureller Kriterien zur vaginosonographischen Beurteilung des postmenopausalen Endometriums. Zbl Gyäcol 114: 420–424Google Scholar
  23. 23.
    Maly Z, Dorr A, Pilka L (1992) Results of transvaginal ultrasound screening for endometrial carcinoma in women at risk after menopause. Cesk Gynecol 57: 108–112Google Scholar
  24. 24.
    Dallenbach-Hellweg G (1987) Histopathology of the endometrium, 4. edn. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  25. 25.
    Meuwissen JH, van Langen H, Moret E, NavarroMorquecho I (1992) Monitoring of oestrogen replacement therapy by vaginosonography of the endometrium. Maturitas 1533–37Google Scholar
  26. 26.
    Kurjak A, Kupesic-Urek S, Miric D (1992) The assessment of benign uterine tumor vascularization by transvaginal color Doppler. Ultrasound Med Biol 18: 645–648PubMedCrossRefGoogle Scholar
  27. 27.
    Kurjak A, Zalud I (1991) The characterization of uterine tumors by transvaginal color Doppler. Ultrasound Obstet Gynecol 1: 50–52PubMedCrossRefGoogle Scholar
  28. 28.
    Bourne TH, Campbell S, Steer CV, Royston P, Whitehead M, Collins WP (1991) Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: a preliminary report. Gynecol Oncol 40 253–259PubMedCrossRefGoogle Scholar
  29. 29.
    Bourne TH, Campbell S, Whitehead MI, Royston P, Steer CV, Collins WP (1990) Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and color flow imaging. Br Med J 301: 369–374CrossRefGoogle Scholar
  30. 30.
    Hata K, Hata T, Manabe A, Makihara K, Kitao M (1992) New pelvic sonography for detection of endometrial carcinoma: a preliminary report. Gynecol Oncol 45: 179–184PubMedCrossRefGoogle Scholar
  31. 31.
    Kedar RP, Bourne TH, Powles TJ, Collins W, Ashley SE, Cosgrove DO, Campbell S (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343: 1318–1321PubMedCrossRefGoogle Scholar
  32. 32.
    Hulka CA, Hall DA (1993) Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. Am J Radio’ 160: 809–812Google Scholar
  33. 33.
    Anteby E, Yagel S, Zacut D, Palti Z, Hochner-Celnikier D (1992) False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen. Lancet 340: 433–434PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • R. G. W. Osmers

There are no affiliations available

Personalised recommendations